VICTOR L. CRAWFORD

CIK 1449780 · CEO, Pharmaceutical Segment · last filed 2025-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.72M

Companies

4

Total Filings

44

Lifetime Open-Market Net

-$687.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HSY Director 4,885 $181.66 $887.5K $0 22 2025-04-03
CAH CEO, Pharmaceutical Segment 105,699 $223.85 $23.66M $0 10 2022-08-17
PLAY Director 13,409 $12.93 $173.4K $0 5 2020-04-28
PEPSI BOTTLING GROUP INC (PBG) Delisted SVP, Glbl Ops&Sys Transformatn 0 -$687.9K 7 2010-02-26

Recent Filings · Page 3 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-08-17 CAH Mixed +1,286 -$1.03M EDGAR
2021-08-05 CAH Grant (A) +23,946 $0 EDGAR
2021-07-01 HSY Grant (A) +230 $0 EDGAR
2021-04-05 HSY Grant (A) +250 $0 EDGAR
2021-01-05 HSY Grant (A) +264 $0 EDGAR
2020-11-17 CAH Tax (F) −4,362 -$250.5K EDGAR
2020-10-05 HSY Grant (A) +282 $0 EDGAR
2020-08-17 CAH Mixed +17,412 -$165.3K EDGAR
2020-07-01 HSY Grant (A) +477 $0 EDGAR
2020-04-28 PLAY Grant (A) +4,504 $0 EDGAR
Showing 2130 of 44
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.